QURE

$0.00

(

0.00%

)
Quote details

stock

Uniqure NV

NASDAQ | QURE

34.29

USD

$0.00

(

0.00%

)

At Close (As of Nov 3, 2025)

$4.17B

Market Cap

-

P/E Ratio

-3.9

EPS

$71.50

52 Week High

$5.35

52 Week Low

HEALTHCARE

Sector

QURE Chart

Recent Chart
Price Action

QURE Technicals

Tags:

QURE Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $8.8M
Total Revenue $27M
Cost Of Revenue $18M
Costof Goods And Services Sold $18M
Operating Income -$184M
Selling General And Administrative $51M
Research And Development $144M
Operating Expenses $196M
Investment Income Net -
Net Interest Income -$42M
Interest Income $21M
Interest Expense $64M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $13M
Income Before Tax -$237M
Income Tax Expense $2.4M
Interest And Debt Expense -
Net Income From Continuing Operations -$240M
Comprehensive Income Net Of Tax -
Ebit -$173M
Ebitda -$161M
Net Income -$240M

Revenue & Profitability

Earnings Performance

QURE Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $557M
Total Current Assets $390M
Cash And Cash Equivalents At Carrying Value $159M
Cash And Short Term Investments $159M
Inventory $0
Current Net Receivables $5.9M
Total Non Current Assets $166M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $71M
Intangible Assets Excluding Goodwill $71M
Goodwill $22M
Investments -
Long Term Investments $27M
Short Term Investments $209M
Other Current Assets $17M
Other Non Current Assets -
Total Liabilities $563M
Total Current Liabilities $40M
Current Accounts Payable $7.2M
Deferred Revenue -
Current Debt -
Short Term Debt $7.2M
Total Non Current Liabilities $523M
Capital Lease Obligations $15M
Long Term Debt $51M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $66M
Other Current Liabilities $26M
Other Non Current Liabilities $454M
Total Shareholder Equity -$6.8M
Treasury Stock -
Retained Earnings -$1.1B
Common Stock $2.9M
Common Stock Shares Outstanding $49M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$183M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $13M
Capital Expenditures $3.4M
Change In Receivables -
Change In Inventory $2.4M
Profit Loss -
Cashflow From Investment $163M
Cashflow From Financing -$59M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$240M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $8.8M
Total Revenue $27M
Cost Of Revenue $18M
Costof Goods And Services Sold $18M
Operating Income -$184M
Selling General And Administrative $51M
Research And Development $144M
Operating Expenses $196M
Investment Income Net -
Net Interest Income -$42M
Interest Income $21M
Interest Expense $64M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $13M
Income Before Tax -$237M
Income Tax Expense $2.4M
Interest And Debt Expense -
Net Income From Continuing Operations -$240M
Comprehensive Income Net Of Tax -
Ebit -$173M
Ebitda -$161M
Net Income -$240M

QURE News

QURE Profile

Uniqure NV Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

uniQure NV is a pioneering gene therapy company focused on developing innovative treatments for patients with genetic disorders and other severe diseases. Headquartered in Amsterdam, the Netherlands, uniQure leverages its proprietary AAV-based gene therapy platform to address unmet medical needs, aiming to provide long-lasting solutions for conditions such as hemophilia and neurodegenerative diseases. With a robust pipeline of product candidates and a commitment to transforming patient care through advanced genetic treatments, uniQure is positioned as a leader in the evolving field of gene therapy.

MSPR
+136.59%
$0.52
VHAI
+21.21%
$0.00
EZGO
+29.10%
$0.17
KVUE
+12.31%
$16.14
NVDA
+2.16%
$206.88
PHIO
-9.26%
$1.86
WTO
+14.47%
$0.05
BYND
-16.01%
$1.39
ASST
-4.51%
$1.27
RAY
+31.93%
$0.21
PFE
+0.04%
$24.66
CIFR
+22.03%
$22.76
ONDS
-4.50%
$6.15
BITF
+3.52%
$4.11
YDKG
-0.71%
$0.05
DNN
-8.04%
$2.91
PLUG
+2.23%
$2.75
AMZN
+4.00%
$254.00
FEMY
+3.13%
$0.65
T
-0.88%
$24.53
YGMZ
+6.92%
$0.13
TSLA
+2.58%
$468.37
QS
+16.78%
$18.44
SOFI
+3.20%
$30.63
F
-0.91%
$13.01
IREN
+11.52%
$67.75
GRAB
+0.99%
$6.07
CHR
+0.48%
$0.12
NGD
-0.81%
$7.28
ACHR
-7.13%
$10.42
PLTR
+3.34%
$207.18
CRBU
+0.41%
$2.43
AXDX
-61.36%
$0.03
GPUS
-6.74%
$0.37
EPWK
-15.55%
$0.07
DVLT
-9.35%
$1.84
MSAI
+26.92%
$1.98
TGE
-53.70%
$0.77
WULF
+3.87%
$16.10
NOK
+3.47%
$7.15
INTC
-1.22%
$39.50
RGTI
-11.63%
$39.11
RIG
+3.12%
$3.96
BURU
-6.99%
$0.31
NIO
+2.34%
$7.42
AAL
+1.59%
$13.34
BTG
-3.18%
$4.25
ADAP
-15.14%
$0.05
FUBO
-8.46%
$3.46
AREC
+3.89%
$4.00
RXRX
-1.44%
$5.44
AAPL
-0.48%
$269.05
IOVA
-3.40%
$1.90
THAR
+8.47%
$3.20
QBTS
-10.71%
$33.09
RNTX
+11.82%
$1.75
SNAP
+2.63%
$7.80
LUMN
+15.07%
$11.83
JOBY
-5.88%
$16.32
WBD
-0.71%
$22.29
TLRY
+3.87%
$1.34
ETHD
+15.50%
$4.34
RMBL
+60.50%
$3.21
VZ
-0.67%
$39.47
CAN
-9.09%
$1.30
MARA
-2.51%
$17.80
ADD
-25.47%
$0.05
RIVN
-2.80%
$13.19
VALE
+0.90%
$12.20
KMB
-14.56%
$102.27
BMNR
-8.12%
$42.86
AMD
+1.37%
$259.64
BTBT
-6.55%
$3.42
UUUU
-13.21%
$17.80
CDE
-11.82%
$15.14
SRM
+53.27%
$10.30
PBR
+1.54%
$11.82
BBD
+2.07%
$3.45
HIMS
-2.35%
$44.39
TERN
+69.85%
$14.03
RIOT
+4.75%
$20.72
AMCR
-0.50%
$7.86
CMG
-0.59%
$31.50
META
-1.64%
$637.71
NVTS
-8.98%
$12.25
QUBT
-7.95%
$15.38
CLSK
-2.13%
$17.42
CLF
-4.50%
$11.87
BAC
+0.20%
$53.56
CURR
-36.24%
$2.41
PRLD
+150.31%
$3.98
QURE
-49.34%
$34.29
ABEV
+1.73%
$2.35
LAZR
+17.24%
$1.36
PCG
-0.31%
$15.91
LAES
-13.07%
$6.45
CORZ
+6.31%
$22.90
PLTZ
-6.93%
$5.23
GOOGL
+0.89%
$283.72
UBER
+3.33%
$99.72
MSPR
+136.59%
$0.52
VHAI
+21.21%
$0.00
EZGO
+29.10%
$0.17
KVUE
+12.31%
$16.14
NVDA
+2.16%
$206.88
PHIO
-9.26%
$1.86
WTO
+14.47%
$0.05
BYND
-16.01%
$1.39
ASST
-4.51%
$1.27
RAY
+31.93%
$0.21
PFE
+0.04%
$24.66
CIFR
+22.03%
$22.76
ONDS
-4.50%
$6.15
BITF
+3.52%
$4.11
YDKG
-0.71%
$0.05
DNN
-8.04%
$2.91
PLUG
+2.23%
$2.75
AMZN
+4.00%
$254.00
FEMY
+3.13%
$0.65
T
-0.88%
$24.53
YGMZ
+6.92%
$0.13
TSLA
+2.58%
$468.37
QS
+16.78%
$18.44
SOFI
+3.20%
$30.63
F
-0.91%
$13.01
IREN
+11.52%
$67.75
GRAB
+0.99%
$6.07
CHR
+0.48%
$0.12
NGD
-0.81%
$7.28
ACHR
-7.13%
$10.42
PLTR
+3.34%
$207.18
CRBU
+0.41%
$2.43
AXDX
-61.36%
$0.03
GPUS
-6.74%
$0.37
EPWK
-15.55%
$0.07
DVLT
-9.35%
$1.84
MSAI
+26.92%
$1.98
TGE
-53.70%
$0.77
WULF
+3.87%
$16.10
NOK
+3.47%
$7.15
INTC
-1.22%
$39.50
RGTI
-11.63%
$39.11
RIG
+3.12%
$3.96
BURU
-6.99%
$0.31
NIO
+2.34%
$7.42
AAL
+1.59%
$13.34
BTG
-3.18%
$4.25
ADAP
-15.14%
$0.05
FUBO
-8.46%
$3.46
AREC
+3.89%
$4.00
RXRX
-1.44%
$5.44
AAPL
-0.48%
$269.05
IOVA
-3.40%
$1.90
THAR
+8.47%
$3.20
QBTS
-10.71%
$33.09
RNTX
+11.82%
$1.75
SNAP
+2.63%
$7.80
LUMN
+15.07%
$11.83
JOBY
-5.88%
$16.32
WBD
-0.71%
$22.29
TLRY
+3.87%
$1.34
ETHD
+15.50%
$4.34
RMBL
+60.50%
$3.21
VZ
-0.67%
$39.47
CAN
-9.09%
$1.30
MARA
-2.51%
$17.80
ADD
-25.47%
$0.05
RIVN
-2.80%
$13.19
VALE
+0.90%
$12.20
KMB
-14.56%
$102.27
BMNR
-8.12%
$42.86
AMD
+1.37%
$259.64
BTBT
-6.55%
$3.42
UUUU
-13.21%
$17.80
CDE
-11.82%
$15.14
SRM
+53.27%
$10.30
PBR
+1.54%
$11.82
BBD
+2.07%
$3.45
HIMS
-2.35%
$44.39
TERN
+69.85%
$14.03
RIOT
+4.75%
$20.72
AMCR
-0.50%
$7.86
CMG
-0.59%
$31.50
META
-1.64%
$637.71
NVTS
-8.98%
$12.25
QUBT
-7.95%
$15.38
CLSK
-2.13%
$17.42
CLF
-4.50%
$11.87
BAC
+0.20%
$53.56
CURR
-36.24%
$2.41
PRLD
+150.31%
$3.98
QURE
-49.34%
$34.29
ABEV
+1.73%
$2.35
LAZR
+17.24%
$1.36
PCG
-0.31%
$15.91
LAES
-13.07%
$6.45
CORZ
+6.31%
$22.90
PLTZ
-6.93%
$5.23
GOOGL
+0.89%
$283.72
UBER
+3.33%
$99.72

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.